 Kerry Hildreth
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testosterone | 11 | 2026 | 416 | 1.810 |
Why?
| | Menopause | 9 | 2022 | 326 | 1.470 |
Why?
| | Endothelium, Vascular | 11 | 2026 | 956 | 1.150 |
Why?
| | Aging | 9 | 2026 | 1973 | 0.920 |
Why?
| | Cognition Disorders | 3 | 2014 | 544 | 0.880 |
Why?
| | Vascular Stiffness | 3 | 2024 | 487 | 0.820 |
Why?
| | Cardiovascular Diseases | 7 | 2024 | 2191 | 0.660 |
Why?
| | Brachial Artery | 7 | 2025 | 208 | 0.580 |
Why?
| | Hypogonadism | 3 | 2024 | 93 | 0.560 |
Why?
| | Compliance | 2 | 2018 | 50 | 0.550 |
Why?
| | Carotid Arteries | 3 | 2024 | 208 | 0.550 |
Why?
| | Dementia | 3 | 2021 | 328 | 0.530 |
Why?
| | Vasodilation | 7 | 2025 | 521 | 0.510 |
Why?
| | Oxidative Stress | 7 | 2026 | 1360 | 0.480 |
Why?
| | Geriatric Assessment | 2 | 2014 | 240 | 0.450 |
Why?
| | Resistance Training | 2 | 2021 | 186 | 0.450 |
Why?
| | Sex Characteristics | 1 | 2020 | 789 | 0.420 |
Why?
| | Memory Disorders | 1 | 2014 | 197 | 0.390 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2013 | 43 | 0.380 |
Why?
| | Hormone Replacement Therapy | 1 | 2013 | 107 | 0.350 |
Why?
| | Aged | 26 | 2026 | 26217 | 0.340 |
Why?
| | Disease Susceptibility | 1 | 2013 | 344 | 0.330 |
Why?
| | Depression | 2 | 2018 | 1559 | 0.330 |
Why?
| | Premenopause | 4 | 2020 | 125 | 0.320 |
Why?
| | Medicare | 3 | 2021 | 904 | 0.300 |
Why?
| | Cognition | 2 | 2016 | 1271 | 0.280 |
Why?
| | Vascular Diseases | 2 | 2022 | 252 | 0.270 |
Why?
| | Postmenopause | 4 | 2020 | 394 | 0.250 |
Why?
| | Quality of Life | 2 | 2023 | 3211 | 0.250 |
Why?
| | Perimenopause | 2 | 2020 | 69 | 0.250 |
Why?
| | Fee-for-Service Plans | 4 | 2021 | 99 | 0.240 |
Why?
| | Sirtuins | 1 | 2026 | 50 | 0.230 |
Why?
| | Alzheimer Disease | 1 | 2012 | 630 | 0.220 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2004 | 31 | 0.210 |
Why?
| | Ascorbic Acid | 2 | 2016 | 184 | 0.200 |
Why?
| | Adipose Tissue, Brown | 1 | 2024 | 60 | 0.200 |
Why?
| | Ultrasonography | 3 | 2018 | 788 | 0.200 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 125 | 0.200 |
Why?
| | Erectile Dysfunction | 1 | 2023 | 38 | 0.200 |
Why?
| | Humans | 35 | 2026 | 145783 | 0.200 |
Why?
| | Endothelin-1 | 1 | 2025 | 181 | 0.190 |
Why?
| | Insulin Resistance | 1 | 2012 | 1244 | 0.190 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2024 | 161 | 0.190 |
Why?
| | Body Composition | 2 | 2020 | 693 | 0.190 |
Why?
| | Middle Aged | 16 | 2026 | 36309 | 0.190 |
Why?
| | Phosphoproteins | 1 | 2004 | 337 | 0.180 |
Why?
| | Estradiol | 3 | 2020 | 515 | 0.180 |
Why?
| | Baroreflex | 1 | 2022 | 57 | 0.180 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2022 | 203 | 0.170 |
Why?
| | Mental Status and Dementia Tests | 1 | 2021 | 27 | 0.160 |
Why?
| | Insulin | 1 | 2012 | 2516 | 0.160 |
Why?
| | Walk Test | 1 | 2021 | 82 | 0.160 |
Why?
| | Female | 22 | 2024 | 79045 | 0.160 |
Why?
| | Hyperemia | 1 | 2020 | 49 | 0.160 |
Why?
| | Bone Density | 2 | 2021 | 487 | 0.160 |
Why?
| | Obesity | 2 | 2023 | 3118 | 0.150 |
Why?
| | Hip Fractures | 1 | 2021 | 87 | 0.150 |
Why?
| | Endothelial Cells | 1 | 2026 | 878 | 0.150 |
Why?
| | Preventive Medicine | 1 | 2019 | 39 | 0.150 |
Why?
| | Male | 20 | 2026 | 73011 | 0.150 |
Why?
| | Brain | 1 | 2012 | 2969 | 0.150 |
Why?
| | Androgens | 2 | 2021 | 181 | 0.150 |
Why?
| | Mitochondria | 1 | 2026 | 993 | 0.150 |
Why?
| | Neuropsychological Tests | 2 | 2014 | 1137 | 0.140 |
Why?
| | Ovary | 1 | 2020 | 234 | 0.140 |
Why?
| | Homocysteine | 1 | 2019 | 152 | 0.140 |
Why?
| | Nootropic Agents | 1 | 2018 | 30 | 0.140 |
Why?
| | Medicare Part D | 1 | 2018 | 23 | 0.140 |
Why?
| | Energy Metabolism | 2 | 2024 | 935 | 0.140 |
Why?
| | Adult | 14 | 2026 | 40881 | 0.140 |
Why?
| | Executive Function | 2 | 2013 | 470 | 0.130 |
Why?
| | Young Adult | 7 | 2026 | 14254 | 0.130 |
Why?
| | Cross-Sectional Studies | 6 | 2026 | 5925 | 0.130 |
Why?
| | Cysteine | 1 | 2019 | 211 | 0.130 |
Why?
| | Antioxidants | 2 | 2022 | 550 | 0.130 |
Why?
| | Aged, 80 and over | 5 | 2019 | 8347 | 0.120 |
Why?
| | Preventive Health Services | 1 | 2018 | 153 | 0.120 |
Why?
| | Arginine | 1 | 2017 | 264 | 0.120 |
Why?
| | Analysis of Variance | 1 | 2018 | 1300 | 0.110 |
Why?
| | Affect | 1 | 2018 | 321 | 0.110 |
Why?
| | Estrogens | 3 | 2024 | 367 | 0.110 |
Why?
| | Medical History Taking | 1 | 2014 | 117 | 0.110 |
Why?
| | Myocardial Infarction | 1 | 2022 | 1211 | 0.100 |
Why?
| | Physical Examination | 1 | 2014 | 244 | 0.100 |
Why?
| | Lost to Follow-Up | 1 | 2013 | 20 | 0.100 |
Why?
| | Sex Hormone-Binding Globulin | 1 | 2013 | 52 | 0.100 |
Why?
| | Ventricular Function, Left | 1 | 2016 | 544 | 0.090 |
Why?
| | Patient Acceptance of Health Care | 1 | 2019 | 883 | 0.090 |
Why?
| | Patient Dropouts | 1 | 2013 | 66 | 0.090 |
Why?
| | Waist Circumference | 1 | 2013 | 143 | 0.090 |
Why?
| | Health | 1 | 2012 | 82 | 0.090 |
Why?
| | Upper Extremity | 1 | 2013 | 113 | 0.090 |
Why?
| | Blood Pressure | 2 | 2022 | 1782 | 0.090 |
Why?
| | Healthcare Disparities | 1 | 2018 | 736 | 0.080 |
Why?
| | Health Surveys | 1 | 2013 | 520 | 0.080 |
Why?
| | Terminal Care | 1 | 2014 | 283 | 0.080 |
Why?
| | Signal Transduction | 1 | 2004 | 5224 | 0.080 |
Why?
| | Disease Management | 1 | 2014 | 653 | 0.080 |
Why?
| | Muscle Strength | 1 | 2013 | 332 | 0.080 |
Why?
| | Combined Modality Therapy | 1 | 2013 | 1271 | 0.080 |
Why?
| | Absorptiometry, Photon | 2 | 2021 | 277 | 0.080 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1791 | 0.080 |
Why?
| | Activities of Daily Living | 1 | 2013 | 444 | 0.070 |
Why?
| | Follicle Stimulating Hormone | 2 | 2021 | 266 | 0.070 |
Why?
| | Patient Compliance | 1 | 2013 | 588 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2028 | 0.070 |
Why?
| | Heart Failure | 1 | 2022 | 2326 | 0.070 |
Why?
| | Motor Activity | 1 | 2013 | 718 | 0.070 |
Why?
| | Exercise | 1 | 2020 | 2205 | 0.070 |
Why?
| | Disease Progression | 1 | 2014 | 2865 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 6085 | 0.060 |
Why?
| | Nitric Oxide | 2 | 2022 | 892 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2933 | 0.050 |
Why?
| | beta-Adrenergic Receptor Kinases | 1 | 2004 | 4 | 0.050 |
Why?
| | G-Protein-Coupled Receptor Kinase 3 | 1 | 2004 | 2 | 0.050 |
Why?
| | Sodium-Hydrogen Exchangers | 1 | 2004 | 23 | 0.050 |
Why?
| | Diabetes Mellitus | 1 | 2013 | 1101 | 0.050 |
Why?
| | Epidermal Growth Factor | 1 | 2004 | 162 | 0.050 |
Why?
| | Thermogenesis | 1 | 2024 | 45 | 0.050 |
Why?
| | Socioeconomic Factors | 2 | 2018 | 1327 | 0.050 |
Why?
| | Women's Health | 2 | 2019 | 316 | 0.050 |
Why?
| | Serine | 1 | 2004 | 143 | 0.050 |
Why?
| | Pulse Wave Analysis | 1 | 2024 | 267 | 0.050 |
Why?
| | Peroxynitrous Acid | 1 | 2022 | 11 | 0.050 |
Why?
| | Colorado | 1 | 2013 | 4556 | 0.050 |
Why?
| | Blood Glucose | 1 | 2013 | 2344 | 0.050 |
Why?
| | Cold Temperature | 1 | 2024 | 206 | 0.050 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2024 | 217 | 0.050 |
Why?
| | Positron-Emission Tomography | 1 | 2024 | 343 | 0.040 |
Why?
| | Transfection | 1 | 2004 | 927 | 0.040 |
Why?
| | Cattle | 1 | 2004 | 946 | 0.040 |
Why?
| | Plethysmography | 1 | 2022 | 104 | 0.040 |
Why?
| | Animals | 2 | 2020 | 38102 | 0.040 |
Why?
| | United States | 4 | 2021 | 16126 | 0.040 |
Why?
| | Risk Factors | 2 | 2013 | 10919 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2022 | 126 | 0.040 |
Why?
| | Clinical Trials, Phase III as Topic | 1 | 2021 | 116 | 0.040 |
Why?
| | Administration, Topical | 1 | 2021 | 155 | 0.040 |
Why?
| | Insurance Claim Review | 1 | 2021 | 83 | 0.040 |
Why?
| | Communicable Disease Control | 1 | 2021 | 86 | 0.040 |
Why?
| | Blood Flow Velocity | 1 | 2022 | 421 | 0.040 |
Why?
| | Phosphorylation | 1 | 2004 | 1708 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 413 | 0.040 |
Why?
| | Cell Line | 1 | 2004 | 2823 | 0.040 |
Why?
| | Fibroblasts | 1 | 2004 | 1028 | 0.040 |
Why?
| | Glucose | 1 | 2024 | 1049 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 2020 | 514 | 0.030 |
Why?
| | Heart Rate | 1 | 2022 | 856 | 0.030 |
Why?
| | Adolescent | 3 | 2026 | 22577 | 0.030 |
Why?
| | Protein Binding | 1 | 2004 | 2240 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2022 | 780 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3346 | 0.030 |
Why?
| | Independent Living | 1 | 2018 | 116 | 0.030 |
Why?
| | Patient Participation | 1 | 2021 | 446 | 0.030 |
Why?
| | Recovery of Function | 1 | 2021 | 716 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1069 | 0.030 |
Why?
| | Nutritional Status | 1 | 2019 | 353 | 0.030 |
Why?
| | Diastole | 1 | 2016 | 146 | 0.030 |
Why?
| | Mitral Valve | 1 | 2016 | 95 | 0.030 |
Why?
| | Residence Characteristics | 1 | 2018 | 375 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1752 | 0.030 |
Why?
| | Kidneys, Artificial | 1 | 1993 | 6 | 0.030 |
Why?
| | Microcomputers | 1 | 1993 | 18 | 0.020 |
Why?
| | Biomarkers | 1 | 2025 | 4302 | 0.020 |
Why?
| | Patient-Centered Care | 1 | 2018 | 547 | 0.020 |
Why?
| | Echocardiography | 1 | 2016 | 648 | 0.020 |
Why?
| | Urea | 1 | 1993 | 85 | 0.020 |
Why?
| | Telemedicine | 1 | 2021 | 967 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2016 | 756 | 0.020 |
Why?
| | Diet | 1 | 2019 | 1278 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2018 | 1101 | 0.020 |
Why?
| | Computer Simulation | 1 | 1993 | 1003 | 0.020 |
Why?
| | Mice | 1 | 2004 | 18356 | 0.020 |
Why?
| | Cohort Studies | 1 | 2012 | 6033 | 0.010 |
Why?
| | Uremia | 1 | 1993 | 15 | 0.010 |
Why?
| | Metabolic Clearance Rate | 1 | 1993 | 115 | 0.010 |
Why?
| | Software | 1 | 1993 | 680 | 0.000 |
Why?
|
|
Hildreth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|